Report International

Patient-centered TB care requires interventions tailored to each stage of the TB continuum. In a recent review, authors from RePORT Korea and RePORT Brazil — Drs. Jinsoo Min, Bruno B. Andrade, Ju Sang Kim, and Yoolwon Jeong — discuss approaches involving drug development, host-directed therapies, and biomarkers to support more individualized TB care and policy development.

🔗 Read the review: https://www.e-emj.org/journal/view.php?number=1612

Bridging science and policy in tuberculosis treatment through innovations in precision medicine, drug development, and cohort research: a narrative review Bridging science and policy in tuberculosis treatment through innovations in precision medicine, drug development, and cohort research: a narrative review

“What? No sputum needed?” A recent NPR story highlights emerging tongue swab testing approaches for tuberculosis. These non-invasive sampling methods may help expand access to TB diagnostics and simplify testing in a variety of clinical and community settings.

🔗 Listen to the story: https://www.npr.org/2026/04/29/nx-s1-5802789/tb-tuberculosis-rapid-test

Long a dream, it's now real: a fast and accurate TB test that doesn't need phlegm TB tests use phlegm — not the easiest thing to get or work with. It takes time for results. And there can be false negatives and positives. A new test is more accurate and takes less than half an hour.

Did you know that genetic ancestry may influence adverse reactions to TB medications? A recent publication from the RePORT Brazil consortium examines how genetic diversity within highly heterogeneous populations can contribute to variability in treatment responses and medication-related side effects.

🔗 Read the paper: https://pmc.ncbi.nlm.nih.gov/articles/PMC12774987/

Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil Tuberculosis (TB) treatment is highly effective, but response to therapy varies by geography and population subgroups. We assessed differences in TB treatment response in a representative and heterogeneous Brazilian population. We estimated genetic ...

Our May Newsletter is out! We have some very interesting updates including a talk by Prof Ed Nardell from Harvard Medical School.

https://reportinternational.org/wp-content/uploads/2026/05/RePORT-May-2026-Newsletter.pdf

“In primary healthcare settings, pooled testing is a method that should be encouraged in low-income settings like ours… it’s economical and helps to screen more people with the same resources.” — Cameroon KII1, Programme Director.

The Start4All Pooled Testing Toolkit provides practical open-access resources to support National TB Programmes and implementation partners in planning, evaluating, and scaling up pooled sputum testing for TB. Resources include standard operating procedures, checklists, case studies, and instructional videos to support safe and effective implementation.

🔗 Learn more: https://lstmed.ac.uk/start4all/toolkits/?_gl=1*emi3sx*_up*MQ..*_ga*MTUxNjczNzg2NS4xNzc3NjQ1ODgx*_ga_LZF3GEKBBJ*czE3Nzc2NDU4ODEkbzEkZzEkdDE3Nzc2NDU5MzUkajYkbDAkaDA.

A new implementation toolkit for near point-of-care nucleic acid amplification testing (NPOC-NAAT) and swab-based TB testing is now available. Developed through the Stop TB Partnership Global Laboratory Initiative, the toolkit includes planning materials, standard operating procedures, monitoring and evaluation tools, training resources, competency checklists, and quality assurance materials to support implementation of WHO recommendations within national TB programs.

🔗 Explore the toolkit: https://www.stoptb.org/who-we-are/stop-tb-working-groups/global-laboratory-initiative-gli/gli-guidance-and-tools/tb-near-point-care-and-swab-based-testing-toolkit

www.stoptb.org

Stay informed with the RePORT International Weekly E-Bulletin, published every Friday. The bulletin shares timely updates in tuberculosis research, policy, and practice from across the global TB community.

In this week’s edition, you’ll find updates on WHO guidance and implementation resources, emerging diagnostic approaches including tongue swab and pooled testing strategies, new findings from RePORT consortium investigators, highlights recognizing Clinical Trials Day, and recent publications focused on patient-centered TB care and treatment response.

🔗 Read the most recent edition: https://conta.cc/4377g2X

To receive future editions directly, we encourage you to register for our listserv.
hashtag

Dr. Andrade will deliver the 2026 Maria Nikitin Memorial Lecture at the Johns Hopkins Center for TB Research & Tuberculosis Research Advancement Center (TRAC) Annual Scientific Meeting Wednesday, May 13, 2026, from 9:00 a.m. – 4:30 p.m. ET at the Johns Hopkins University School of Nursing Auditorium (S120) and via Zoom.

Stay informed with the RePORT International Weekly E-Bulletin, published every Friday! The RePORT Weekly E-Bulletin shared timely updates in tuberculosis research, policy, and practice from across the global community.

In this week’s edition, you’ll find: new developments in TB diagnostics, updates on treatment strategies, recent guidance from global health organizations, highlights from newly published research, and upcoming events and resources.

🔗 Read the most recent edition: https://myemail.constantcontact.com/Weekly-Education-Bulletin.html?soid=1140293130525&aid=SpSbzeMw2ZY

To receive future editions directly, we encourage you to register for our listserv.

This article showcases how the public and scientific understanding of tuberculosis has changed, highlighting the role of narrative in shaping perceptions of disease, stigma, and care.

🔗 Read more: https://journals.theunion.org/content/ijtldo/3/3/118